Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung ...

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...

Roughly one in five (21 percent) of idiopathic pulmonary fibrosis (IPF) deaths might be related to occupational exposures, according to research published in the March 6 issue of the U.S. Centers for ...

Learn about idiopathic pulmonary fibrosis, its symptoms, diagnosis, and treatment options for managing this lung disease.

The global idiopathic pulmonary fibrosis market size was valued at USD 4.54 billion in 2024 and is projected to reach from ...

GREENVALE, Nassau County (WABC) -- A long COVID survivor is still recovering five years after the pandemic first swept across the world.

Alongside new steps in its therapeutic pipeline—and a new push into laboratory robotics—Insilico Medicine has raised $110 ...

Rentosertib is designed to treat IPF by targeting Traf2- and NCK-interacting kinase (TNIK), a serine/threonine kinase whose activation plays a crucial role in cellular processes that include signal ...

Crown Princess Mette-Marit is rearranging her royal responsibilities as her chronic lung disease has "progressed," the Royal ...

SINGAPORE: A new study from Duke-NUS Medical School has identified a promising new avenue for tackling pulmonary fibrosis, a ...

The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.